Drug-induced kidney injury, or nephrotoxicity, is a common complication in clinical medicine that happens when drugs damage ...

The platform analyses gene expression and cell states specific to individual cells, offering insights for disease diagnosis.

Researchers have identified six new biomarkers that could detect kidney injury faster and with more sensitivity, advancing safer drug development and improving health outcomes for patients. The new ...

NYU researchers found that declining acetyl-L-carnitine and free carnitine levels correlate with Alzheimer’s severity, ...

Denali's DNL343 missed efficacy goals in the HEALEY ALS trial but was well-tolerated. Analysts await detailed biomarker data ...

There’s gouda news for cheese lovers. A recent study found cheese eaters are less likely to have sleep apnea than their dairy ...

BARDA tapped a team of Fred Hutch Cancer Center biostatisticians to determine the biomarkers that will serve as predictors of ...

L'Oreal's new Cell BioPrint device knows your skin better than you do. CES 2025 in Las Vegas is off to a great start -- especially for the intersection of beauty and tech. On Monday L'Oreal unveiled ...

The following is a summary of “lncRNA six3os1 diagnoses acute stroke, predicts disease severity, and predicts post-stroke ...

TMB and various biomarkers were positively associated with improved pCR and EFS in high-risk, early-stage TNBC, regardless of ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with Genialis, the RNA-biomarker company.

An innovative push towards the early diagnosis of schizophrenia comes from the discovery in the blood of two indicators of this disorder, the causes of which remain largely unknown: these are ...